| Recruiting | Study to Evaluate the Safety, Tolerability, Efficacy and Pharmacokinetics of JTE-162 in Subjects With Cryopyri Cryopyrin-associated Periodic Syndromes (CAPS) | Phase 1 | 2026-02-02 |
| Active Not Recruiting | Evaluate Efficacy, Safety and Tolerability of JTT-861 in Subjects With Heart Failure With Reduced Ejection Fra Chronic Heart Failure | Phase 2 | 2023-12-20 |
| Completed | Study to Evaluate Safety, Tolerability, Pharmacokinetics & Pharmacodynamics of JTT-662 in Subjects With Type 2 Diabetes Mellitus, Type 2 | Phase 1 | 2020-06-15 |
| Withdrawn | Study to Evaluate Efficacy and Safety of JTT-251 in Participants With Pulmonary Arterial Hypertension Pulmonary Arterial Hypertension | Phase 2 | 2019-03-01 |
| Completed | Study to Evaluate the Efficacy and Safety of JTE-451 in Subjects With Moderate to Severe Plaque Psoriasis Plaque Psoriasis, Psoriasis, Skin Diseases | Phase 2 | 2019-01-17 |
| Terminated | Study to Evaluate the Safety and Efficacy of JTE-051 in Subjects With Moderate to Severe Plaque Psoriasis Plaque Psoriasis, Skin Diseases | Phase 2 | 2017-11-10 |
| Completed | Study to Evaluate Safety,Tolerability,Pharmacodynamics & Pharmacokinetics of JTE-451 in Active Plaque Psoriasi Plaque Psoriasis, Psoriasis, Skin Diseases | Phase 1 | 2016-12-01 |
| Completed | Study to Evaluate Efficacy, Safety and Tolerability of JTE-051 in Subjects With Active Rheumatoid Arthritis Rheumatoid Arthritis | Phase 2 | 2016-09-14 |
| Completed | Mass Balance Study of JTZ-951 in Subjects With End-stage Renal Disease on Hemodialysis Anemia of Chronic Kidney Disease | Phase 1 | 2016-06-01 |
| Completed | Study to Evaluate Effect of Lapatinib on Pharmacokinetics of JTZ-951 in Subjects With End-stage Renal Disease Anemia of Chronic Kidney Disease | Phase 1 | 2015-10-01 |
| Terminated | Study of Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Single Oral Doses of JTT-252 Diabetes Mellitus | Phase 1 | 2014-04-01 |
| Completed | Study of Safety, Tolerability and Pharmacokinetics of Single Oral JTT-251 Doses in Healthy and Type 2 Diabetic Diabetes Mellitus | Phase 1 | 2014-03-01 |
| Completed | Effect of Hemodialysis on the PK of JTZ-951 in Subjects With End-stage Renal Disease Anemia in Chronic Kidney Disease | Phase 1 | 2013-10-01 |
| Completed | Safety, Tolerability, PK & PD Study of JTZ-951 in Anemic Subjects With End-stage Renal Disease Anemia of Chronic Kidney Disease | Phase 1 | 2013-05-01 |
| Completed | Safety and Efficacy Study of JTT-851 in Patients With Type 2 Diabetes Mellitus Type 2 Diabetes Mellitus | Phase 2 | 2012-09-01 |
| Completed | Study to Assess Safety,Tolerability,Pharmacokinetics & Antiviral Activity of JTK-853 in Hepatitis C Virus Geno Hepatitis C Virus Infection, Response to Therapy of | Phase 1 | 2010-08-01 |
| Terminated | Two Week Study Evaluating Safety, Tolerability and Pharmacokinetics of Multiple Doses of JTK-853 in Healthy Su Healthy | Phase 1 | 2010-03-01 |
| Completed | Safety, Tolerability and Pharmacokinetics Study Assessing Ascending Single Oral JTK-853 Doses in Healthy Subje Healthy | Phase 1 | 2010-01-01 |
| Terminated | Efficacy and Safety Study of JTT-654 in Type 2 Diabetic Patients Type II Diabetes Mellitus | Phase 2 | 2009-09-01 |
| Completed | Safety and Efficacy Study of JTT-130 in Obese Type 2 Diabetic Patients Type II Diabetes Mellitus | Phase 2 | 2009-06-01 |
| Completed | Safety Study of JTT-302 in Subjects With Low HDL-C Levels Dyslipidemia | Phase 2 | 2007-01-01 |
| Completed | Efficacy and Safety Study of JTT-302 in Subjects With Low HDL-C Levels Dyslipidemia | Phase 2 | 2006-12-01 |
| Completed | Safety and Efficacy Study of JTT-705 in Combination With Simvastatin 40 mg in Patients With Low High-Density L Dyslipidemia | Phase 2 | 2004-02-01 |
| Completed | Safety and Efficacy Study of JTT-705 in Combination With Atorvastatin 20 mg in Patients With Low High-Density Dyslipidemia | Phase 2 | 2004-01-01 |
| Completed | Efficacy and Safety Study of JTT-705 in Combination With Pravastatin 40 mg in Patients With Type II Hyperlipid Type II Hyperlipidemia | Phase 2 | 2002-06-01 |